Investment
Participated in Thyme Care's $125M+ Series E led by Morgan Health, valuing the oncology company at more than $2B.
Thyme Care
SEP 2, 2026
Every public signal F4 has attached to this firm, with sources and cross-entity links.
Thyme Care
Scan
Clarify Health
Thyme Care
Clarify Health
Robert B. Schulz joins as Managing Director
Concord Innovation Fund II
Brian Gragnolati joins as Executive Partner
Mednition